Profarma Distribuidora De Stock Shares Owned By Insiders
| PFRM3 Stock | BRL 5.95 0.32 5.10% |
Profarma Distribuidora de fundamentals help investors to digest information that contributes to Profarma Distribuidora's financial success or failures. It also enables traders to predict the movement of Profarma Stock. The fundamental analysis module provides a way to measure Profarma Distribuidora's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Profarma Distribuidora stock.
Profarma |
Profarma Distribuidora de Company Shares Owned By Insiders Analysis
Profarma Distribuidora's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Profarma Distribuidora Shares Owned By Insiders | 66.17 % |
Most of Profarma Distribuidora's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profarma Distribuidora de is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 66% of Profarma Distribuidora de are shares owned by insiders. This is 335.9% higher than that of the Health Care Providers & Services sector and notably higher than that of the Health Care industry. The shares owned by insiders for all Brazil stocks is notably lower than that of the firm.
Profarma Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profarma Distribuidora's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profarma Distribuidora could also be used in its relative valuation, which is a method of valuing Profarma Distribuidora by comparing valuation metrics of similar companies.Profarma Distribuidora is currently under evaluation in shares owned by insiders category among related companies.
Profarma Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Shares Owned By Insiders | 66.17 % | |||
| Shares Owned By Institutions | 26.52 % | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 6.41 B | |||
| Gross Profit | 907.57 M | |||
| EBITDA | 225.52 M | |||
| Net Income | 78.19 M | |||
| Cash And Equivalents | 139.49 M | |||
| Cash Per Share | 1.86 X | |||
| Total Debt | 740.04 M | |||
| Debt To Equity | 91.40 % | |||
| Current Ratio | 1.27 X | |||
| Book Value Per Share | 8.86 X | |||
| Cash Flow From Operations | 107.58 M | |||
| Earnings Per Share | 0.71 X | |||
| Target Price | 7.5 | |||
| Number Of Employees | 7.08 K | |||
| Beta | 1.14 | |||
| Market Capitalization | 399.71 M | |||
| Total Asset | 4.03 B | |||
| Retained Earnings | 92 M | |||
| Working Capital | 615 M | |||
| Current Asset | 1.57 B | |||
| Current Liabilities | 951 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 1.29 % | |||
| Net Asset | 4.03 B | |||
| Last Dividend Paid | 0.27 |
About Profarma Distribuidora Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profarma Distribuidora de's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profarma Distribuidora using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profarma Distribuidora de based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |